Product Standards for Reducing Nicotine in Cigarettes

Similar documents
Nicotine Reduction: Harm Reduction not Prohibition

Compensatory smoking from gradual and immediate reduction in cigarette nicotine content

Tobacco Control Tūranga Update Focus on reducing nicotine content in tobacco to help smokers quit

E-Cigarettes: Current Perspective

Electronic Cigarettes, Nicotine and Policy Implications

Peter G. Shields, MD Tobacco Products Scientific Advisory Committee (TPSAC) August 16, 2013

Comparisons Between Adult Menthol and Non-Menthol Smokers Total Exposure Study. Mohamadi Sarkar, M.Pharm., Ph.D Altria Client Services

A HISTORY OF HIGH DOSE NICOTINE SELF-ADMINISTRATION INCREASES THE RATE OF SELF-ADMINISTRATION AT LOW NICOTINE DOSES. Tracy T.

Tobacco dependence more than just the devil we think we know. Penny Truman 29/04/16

Experimental trial on the effectiveness of IQOS compared to e-cigarettes and regular tobacco cigarettes

UMDNJ School of Public Health. Tobacco Dependence Clinic. Annual Report: 2003

Cigarettes and Other Nicotine Products

THE RELATIONSHIP BETWEEN NICOTINE AND BODY WEIGHT: IMPLICATIONS FOR TOBACCO REGULATORY POLICY FROM RATS & HUMANS. Laura Eloise Rupprecht

TOBACCO PRODUCT OR MEDICAL PRODUCT?

Background and Analysis Objectives Methods and Approach

Dual Use: If Electronic Cigarettes are so good, why are there so few exclusive users?. Jonathan Foulds, PhD

A study to examine changes in exposure to cigarette smoke chemicals when a smoker switches to using a tobacco heating product. Part I: Study Design.

Nicotine Reduction Workshop Role of nicotine in smoking behaviour

Cigarettes and Other Tobacco Products

Menthol and Flavour Ban Evaluation Results

Tobacco Addiction. Addiction Terminology. Jack E. Henningfield, PhD Johns Hopkins School of Medicine Pinney Associates

ORIGINAL INVESTIGATION. Randomized Comparative Trial of Nicotine Polacrilex, a Transdermal Patch, Nasal Spray, and an Inhaler

Sleep Problems and Smoking Cessation in Women

Helping Nurses Help Smokers Quit. Beth Allison, FNP BC OHSU Smoking Cessation Center & Tobacco Consult Service

Biomarker of Exposure Reductions Upon Switching for 5 Days from Cigarettes to a Carbon Heated Tobacco Product (CHTP 1.0)

Pharmacotherapy Safety and Efficacy in Adolescent Smoking Cessation

American Vaping Association

Communicating the Risk of Nicotine Delivery Products

Smoking Cessation: A readily modifiable risk factor

FDA s Action Agenda to Reduce Tobacco Related-Cancer Incidence and Mortality

Menthol Cigarette Report

Low-Nitrosamine Dissolvable Tobacco Products Star Scientific, Inc. Part III Initiation and Cessation

Should FDA try to move smokers to e-cigarettes or other less harmful tobacco-nicotine products and, if so, how?

UMASS TOBACCO TREATMENT SPECIALIST CORE TRAINING

ROLL-YOUR-OWN CIGARETTES AS A RISK FACTOR FOR TOBACCO DEPENDENCE IN NEW ZEALAND

Declaration of Conflict of Interest. No potential conflict of interest to disclose with regard to the topics of this presentations.

Electronic Nicotine Delivery Systems

FORMs of TOBACCO. 2 nd of 3 Prep for Session 1

Supplementary Online Content

SAFETY E-CIGS: CLINICAL STUDIES

Smoking Cessation Counseling Strategies

NICOTINE PHARMACOLOGY and PRINCIPLES of ADDICTION. 3 rd of 3 Prep for Session 1

THE INFLUENCE OF CIGARETTE FILTER DESIGN ON THE YIELD AND COMPOSITION OF CIGARETTE SMOKE

WHO Framework Convention on Tobacco Control

National Conference of State Legislatures Legislative Summit: Clearing the Air About E-Cigarettes

Using Significant Others to Motivate Quit Attempts

SMOKING CESSATION FOR PREGNANCY AND BEYOND: A VIRTUAL CLINIC WB2590

DRAFT FOR COMMENT ( ) All Tobacco Products are Deadly and Addictive: Product Diversity Challenges Regulation and Communication

The Consequence of Smoking & Health Benefits of Quitting

Re: Docket No. FDA-2013-N-0521, Menthol in Cigarettes, Tobacco Products; Request for Comments

Tobacco Packages: Ads for tobacco companies or tools for public health?

The Effect of Puff Duration on Smoke Chemistry

HOPE OR HAZARD? What Research Tells Us About Potentially Reduced-Exposure Tobacco Products

Tobacco Cessation, E- Cigarettes and Hookahs

The Pennsylvania State University. The Graduate School. College of Health and Human Development NICOTINE CONTENT DESCRIPTION EFFECTS ON SUBJECTIVE

Using the Balanced-Placebo Design for Parsing Nicotine Administration Effects

9/16/2016. I would feel comfortable dispensing/prescribing varenicline to a patient with a mental health disorder. Learning Objectives

Quality ID #404: Anesthesiology Smoking Abstinence National Quality Strategy Domain: Effective Clinical Care

UPDATE ON PREMARKET TOBACCO PRODUCT AUTHORIZATION PATHWAY

UNITED STATES REGULATION OF TOBACCO PRODUCTS. Presented by Mitch Zeller Center Director FDA Center for Tobacco Products

Use all articles listed

Rationale for Establishing Tobacco Product Regulation

Re: Docket No. FDA-2017-N-6189, RIN 0910-AH86, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes

Can Exercise Enhance Smoking Cessation Outcomes? A Pragmatic Randomized Controlled Trial (Fit2Quit Study)

Heather Dacus, DO, MPH Preventive Medicine Physician Director, Bureau of Chronic Disease Control New York State Department of Health

TRENDS IN TOBACCO UNDERSTAND 5/26/2017 LEARNING OBJECTIVES. Understand the types of tobacco products trending in today s market & associated risks

Might Smoking Rates go up in Flames? Dr John Schoonbee, Chief Medical Officer, Swiss Re

Ian M. Fearon, Madeleine Ashley, Christopher J. Shepperd, Graham Errington. Sheri A. Bowman, John W. Caraway, Peter Chen, Paul R.

MARKETING STANDARDS FOR MEMBERSHIP

SUMMARY: The Food and Drug Administration (FDA) is issuing this advance notice of

Recent Findings from the ITC Project on the Effectiveness of Health Warnings in the Asia Pacific Region

Examples of what to say when intervening with smoking clients. Do you smoke cigarettes or tobacco at all, or have you ever smoked regularly?

Update on Medications for Tobacco Cessation

Raze-On. Tobacco 101

REPORT ON GLOBAL YOUTH TOBACCO SURVEY SWAZILAND

REGULATORY OPTIONS FOR MOVING TO THE ELIMINATION OF SMOKING. Ron Borland PhD

Selected Agent Characteristics. Product type Nicotine dose levels Constituents (e.g., tar, CO) and ingredients (e.g., additives) Market share

RE: Docket No. FDA-2014-N , Electronic Cigarettes and the Public Health

Presented at FDLI Annual Conference, Washington DC, May 4, 2017, 10:45 to 11:30am 1

Why Tobacco Cessation?

FDA Center for Tobacco Products: Tobacco Research and the Population Assessment of Tobacco and Health (PATH) Study

Providing a Science Base for the Evaluation of. Tobacco Products

ELECTRONIC CIGARETTES WHAT S THE BOTTOM LINE?

Diseases caused by Smoking

Smoking It s never too late to quit

ACHIEVING SMOKEFREE AOTEAROA BY2025

Smoking Cessation A Clinicians Perspective. Jeff Wilson, MD

ATTUD APPLICATION FORM FOR WEBSITE LISTING (PHASE 1): TOBACCO TREATMENT SPECIALIST (TTS) TRAINING PROGRAM PROGRAM INFORMATION & OVERVIEW

Measure #404: Anesthesiology Smoking Abstinence National Quality Strategy Domain: Effective Clinical Care

THE IMPORTANCE OF POINT OF SALE

The Burden of Tobacco, Tobacco Control, and Advocacy: Policy Strategies for Oral Health. Robert McMillen, PhD

/msdcenter. msdcenter. Tomorrow in Austin and via Livestream: msdcenter.org

Public Health England s Independent Expert E-Cigarettes Evidence Review

Menthol cigarettes are a public health problem

Slide 1. Slide 2. Slide 3. Reducing Tobacco Use and Nicotine Dependence in Clinical Settings. Goals for Today

Country profile. Myanmar

2 nd European Harm Reduction Conference session. Tobacco and Harm Reduction. Prof. Jacques Cornuz, Policlinique Médicale Universitaire, Lausanne

Addiction and Dependence

Smoking cessation in pregnancy guideline for practice (GL917)

Transcription:

Funding Research reported in this publication was supported by the National Institute on Drug Abuse and Food and Drug Administration Center for Tobacco Products (U54 DA031659). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Food and Drug Administration. Product Standards for Reducing Nicotine in Cigarettes Eric C. Donny, Ph.D. Professor, Department of Psychology, University of Pittsburgh Director, Center for the Evaluation of Nicotine in Cigarettes

Why do people smoke? People smoke for the nicotine -M.A. Russell, 1976

Why do people smoke? but they die from the tar -M.A. Russell, 1976

Why do people smoke? People smoke for the nicotine but they die from the tar -M.A. Russell, 1976

Why do people smoke? People smoke for the nicotine but they die from the tar -M.A. Russell, 1976 Nicotine Content

Family Smoking Prevention and Tobacco Control Act Enables FDA to set product standards for nicotine Cannot be reduced to zero Must consider the risks and benefits to the population as a whole including users and nonusers

Would a product standard requiring very low nicotine levels reduce cigarette use and improve public health?

Two sources of data for today Large clinical trial Rat self-administration

Donny et al., 2015 Purpose: To determine how use of cigarettes varying in nicotine content impacts a wide range of outcomes in a large study of smokers not currently interested in quitting

Design Double-blind, parallel, randomized trial 840 daily smokers 18+ years old 5+ CPD Not planning to quit in next 30 days

Design Baseline Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 AA Usual brand

Design Baseline Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 AA Study cigarettes provided free of charge All subjects menthol matched

Design Nicotine Nicotine Tar Content Yield (ISO) Yield (ISO) GROUPS (7 total) (mg/g) (mg/cig) (mg/cig) 1. Usual brand variable variable variable 2. Normal Nicotine 15.8 ~0.73 ~10 3. Reduced Nicotine 5.2 ~0.24 ~9 33% 4. Very Low Nicotine 2.4 ~0.11 ~9 15% 5. Very Low Nicotine 8% 1.3 ~0.06 ~8 6/7. Very Low Nicotine 3% 0.4 ~0.03 ~9 (or 13) Data provided by NIDA

Design Baseline Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 AA Abstinence Session

Design Baseline Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 AA 30 day Follow-up

Design Screen Baseline Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 AA In person visits (10) Outcome measures Smoking behavior Biomarkers Nicotine dependence Withdrawal and craving Safety

Design Compensation up to $835 Product use No incentive for compliance (or penalty for noncompliance) with study product Emphasis on honest reporting

Study sites

Sample characteristics Age: 42 Female: 42.3% African American: 39.7% High school or less: 44.2% Menthol preferred: 57% CPD: 15.5 CO: 15.1 FTND: 5.1

Does nicotine reduction lead to reduced smoking?

Donny E.C. et al., 2015, NEJM, 373, 1340-9 Cigarettes per day Dose-dependent reduction in total CPD

Donny E.C. et al., 2015, NEJM, 373, 1340-9 Cigarettes per day Dose-dependent reduction in total CPD

Cigarettes per day Donny E.C. et al., 2015, NEJM, 373, 1340-9

Cigarettes per day Donny E.C. et al., 2015, NEJM, 373, 1340-9

Cigarettes per day Donny E.C. et al., 2015, NEJM, 373, 1340-9

Cigarettes per day Donny E.C. et al., 2015, NEJM, 373, 1340-9

Donny E.C. et al., 2015, NEJM, 373, 1340-9 Cigarettes per day 5.2 and above 2.4 and below * *indicates significant (p<.0125) difference compared to 15.8 mg/g (controlling for BL)

Donny E.C. et al., 2015, NEJM, 373, 1340-9 Hypothetical CPD at $6/pack * * * *indicates significant (p<.0125) difference compared to 15.8 mg/g (controlling for BL)

Demand curve * 15.8 mg/g 0.4 mg/g 0 Cost

Take home point #1 Low nicotine content cigarettes reduce smoking relative to normal nicotine cigarettes CPD 0.4 vs. 15.8 mg/g Reduced Reduced Elasticity of demand (hypothetical)

Does nicotine reduction lead to compensatory smoking?

Compensatory smoking These Light cigarettes actually have reduced contain nicotine less nicotine. yield. It would The be content very difficult of the tobacco for smokers is the to same. adjust their With behavior light cigarettes, to maintain smokers nicotine can levels. and do compensate. Machine yield Content and user exposure

Donny E.C. et al., 2015, NEJM, 373, 1340-9 Compensatory smoking No significant differences

Donny E.C. et al., 2015, NEJM, 373, 1340-9 Compensatory smoking * * *indicates significant (p<.0125) difference compared to 15.8 mg/g (controlling for BL)

Compensatory smoking Other studies also fail to find compensation that lasts beyond the first few cigarettes (Benowitz et al. 2012; Hatsukami et al., 2010, 2013, 2015; Donny et al., 2007; Donny and Jones, 2009; MacQueen et al., 2012) CPD similar or less than controls Carbon monoxide similar or less than controls Puff Volume similar or less than controls It is possible some subgroups will compensate (e.g., high dependence; Bandiera et al., 2015)

Take home point #2 Minimal evidence of compensatory smoking CPD CO Puff volume Filter analysis 0.4 vs. 15.8 mg/g Reduced Similar Reduced Underway

Does nicotine reduction lead to decreases in nicotine exposure?

Donny E.C. et al., 2015, NEJM, 373, 1340-9 Biomarkers of exposure * * * *indicates significant (p<.0125) difference compared to 15.8 mg/g (controlling for BL)

Donny E.C. et al., 2015, NEJM, 373, 1340-9 Content vs. Exposure Nicotine content Nicotine exposure 15.8 57% 0.4 97%

The Hotel Study 94% 24 participants smoked only 0.4 mg/g SPECTRUM while residing at a hotel for 4 nights. Nicotine exposure decreased by at least 92-94% 92%

Non-adherence Self-report: Each week, 30-60% of participants assigned to reduced nicotine cigarettes reported smoking other cigarettes. How much? 2-4 CPD (median when non-compliant) When? Most often first thing in morning Biomarkers: TNE at week 6 Only about 25% of participants in the 0.4 mg/g groups had TNE < 6.4 nmol/ml

Take home point #3 Low nicotine content cigarettes reduce nicotine exposure, but people seek out other sources of nicotine Clinical trial TNE Hotel TNE Clinical trial UB cigs 0.4 vs. 15.8 mg/g Reduced 57% Reduced >94% Increased

Does nicotine reduction reduce dependence and/or lead to quitting?

Donny E.C. et al., 2015, NEJM, 373, 1340-9 Dependence * * * *indicates significant (p<.0125) difference compared to 15.8 mg/g (controlling for BL)

Donny E.C. et al., 2015, NEJM, 373, 1340-9 Dependence * *indicates significant (p<.0125) difference compared to 15.8 mg/g (controlling for BL)

Donny E.C. et al., 2015, NEJM, 373, 1340-9 Quit attempts * * *indicates significant (p<.0125) difference compared to 15.8 mg/g

Donny E.C. et al., 2015, NEJM, 373, 1340-9 Cigarettes per day * * * *indicates significant (p<.0125) difference compared to 15.8 mg/g (controlling for BL)

Take home point #4 Low nicotine content cigarettes reduce nicotine dependence and may increase the likelihood that smokers will try to quit FTND & WIDSM Quit attempts at Follow-up CPD at Follow-up 0.4 vs. 15.8 mg/g Reduced Increased Reduced

Does nicotine reduction lead to other potentially harmful unintended consequences?

Potential unintended consequences Compensatory smoking Depression/disrupted affect Decreased positive Increased negative Weight gain Alcohol/drug use Impaired cognitive function Others AEs Platelet activation

Donny E.C. et al., 2015, NEJM, 373, 1340-9 Depression No significant differences in mean CESD scores Approximately 23% had a score 16+ at Week 6 No significant differences between groups 23% of 15.8 mg.g 22% of 0.4 mg/g CESD Maximum score: 60 Commonly use clinical cutoff: 16

Weight gain 0.4 mg/g conditions only * (n=56) (n=164) * * * *

Take home point #5 Low nicotine content cigarettes do not appear to increase depression, but do lead to expected gains in weight CESD Overall & >16 Weight 0.4 vs. 15.8 mg/g Similar Increased Note: a significant portion of participants use other products

Rat self-administration Sprague-Dawley rats 1-hr daily self-administration sessions Respond for intravenous (i.v.) infusions of nicotine

Smith et al., 2013 Nicotine and Tobacco Research

Smith et al., 2013 Nicotine and Tobacco Research Smith et al., 2013 Nicotine and Tobacco Research

Smith et al., 2013 Nicotine and Tobacco Research Smith et al., 2013 Nicotine and Tobacco Research

Smith et al., 2013 Nicotine and Tobacco Research Smith et al., 2013 Nicotine and Tobacco Research

Would nicotine reduction reduce the uptake of smoking?

Initiation of self-administration DOSE 15 60 7.5 3.75 0.0 The just ABOVE threshold dose from the reduction study The just BELOW threshold dose from the reduction study Adult male Sprague-Dawley rats Smith et al., 2014 Exp & Clinical Psychopharm

Initiation of self-administration Adolescents (male or female) fail to acquire at 10 ug/kg or lower Schassburger et al., under review, Nicotine and Tobacco Research

Take home point #6 Reducing nicotine may decrease the uptake of smoking # inf. % acq. Adolescents vs. adults low vs. high nicotine Reduced Reduced Similar or reduced sensitivity

Could other constituents maintain behavior?

Cigarette Smoke Constituents Nicotine: Primary reinforcing constituent > 8,000 other constituents

Cigarette Smoke Constituents Constituent Dose (µg/kg/inf) % Nicotine Minor alkaloids anabasine 0.9 3.0 anatabine 0.09 0.3 cotinine 0.09 0.3 myosmine 0.09 0.3 nornicotine 0.9 3.0 Beta-carbolines harman 0.1 0.3 norharman 0.3 1.0 Acetaldehyde 16 53 + Pre-session inj of MAO inhibitor, 1.0 mg/kg tranylcypromine (TCP)

Cigarette Smoke Constituents Smith et al., 2015, Drug and Alcohol Dependence Smith et al., Under Review

Cigarette Smoke Constituents Smith et al., 2015, Drug and Alcohol Dependence Smith et al., Under Review

Cigarette Smoke Constituents FR3 FR5 Smith et al., 2015, Drug and Alcohol Dependence

Take home point #7 Although most other constituents may have little effect, constituents that inhibit MAO increase the reinforcing effects of low doses of nicotine # infusions at low cost # infusions at high cost Cocktail Non-sign Non-sign MAO inhibition Increased Non-sign

Take home points - summary 1) Very low nicotine content (VLNC) cigarettes reduces smoking relative to normal nicotine cigarettes. 2) VLNC cigarettes lead to minimal evidence for compensatory smoking. 3) VLNC cigarettes reduce nicotine exposure, but people seek out other sources of nicotine. 4) VLNC cigarettes reduce nicotine dependence and may increase the likelihood that smokers will try to quit. 5) VLNC cigarettes do not appear to increase depression in healthy volunteers, but do lead to weight gain similar to cessation. 6) Reducing nicotine decreases the uptake of self-administration in rats. 7) Non-nicotine constituents tend to have minimal effect on rat selfadministration, although constituents that inhibit MAO may increase the reinforcing effects of low doses of nicotine.

Conclusions Reducing nicotine in cigarettes and other combusted tobacco products could improve public health. Large reductions in nicotine content may be necessary to produce the optimal health impact.

Missing in action Core staff Many critically important RAs, students, physicians, nurses, and other staff at all the CENIC project sites NIDA, RTI and 22 nd century FDA & NIH Pitt general counsel and research compliance offices Anyone else I forgot!

Critical question for audience What additional data do you think are necessary before FDA should consider regulating the nicotine content of cigarettes?